NodThera Announces Presentation at the 44th Annual J.P. Morgan Healthcare ConferenceBOSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) -- NodThera, a clinical-stage biotechnology company pioneering a paradigm shift in the treatment of chronic inflammatory diseases through selective NLRP3 inhibition, today announced that Chris Guiffre, J.D., M.B.A., Chief Financial Officer of NodThera, will present at the 44th Annual J.P. Morgan Healthcare Conference being held January 12-15, 2026, in San Francisco, CA.
NodThera Appoints Geoff McDonough, M.D., as Independent Board MemberSeasoned physician-executive with global biopharma leadership experience joins Board at a pivotal stage of clinical and corporate development
